Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-10
2006-10-10
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200
Reexamination Certificate
active
07119070
ABSTRACT:
The invention provides theta defensin analogs having antimicrobial activity. The invention also provides a method of reducing or inhibiting growth or survival of a microorganism in an environment capable of sustaining the growth or survival of the microorganism, comprising administering an effective amount of a theta defensin analog to the environment, thereby reducing or inhibiting the growth or survival of the microorganism.
REFERENCES:
patent: 4543252 (1985-09-01), Lehrer et al.
patent: 4659692 (1987-04-01), Lehrer et al.
patent: 4705777 (1987-11-01), Lehrer et al.
patent: 5242902 (1993-09-01), Murphy et al.
patent: 5324716 (1994-06-01), Selsted et al.
patent: 5422424 (1995-06-01), Selsted et al.
patent: 5459235 (1995-10-01), Selsted et al.
patent: 5464823 (1995-11-01), Lehrer et al.
patent: 5547939 (1996-08-01), Selsted
patent: 5633229 (1997-05-01), Kokryakov et al.
patent: 5693486 (1997-12-01), Lehrer et al.
patent: 5708145 (1998-01-01), Lehrer et al.
patent: 5731149 (1998-03-01), Selsted et al.
patent: 5804553 (1998-09-01), Kokryakov et al.
patent: 5804558 (1998-09-01), Lehrer et al.
patent: 5821224 (1998-10-01), Selsted et al.
patent: 5840498 (1998-11-01), Selsted et al.
patent: 5844072 (1998-12-01), Selsted et al.
patent: 5889152 (1999-03-01), Kokryakov et al.
patent: 5916872 (1999-06-01), Chang et al.
patent: 5994306 (1999-11-01), Chang et al.
patent: 6043220 (2000-03-01), Chang et al.
patent: 6159936 (2000-12-01), Lehrer et al.
patent: 6307016 (2001-10-01), Lehrer et al.
patent: 6335318 (2002-01-01), Selsted et al.
patent: 6492328 (2002-12-01), Lehrer et al.
patent: 6514727 (2003-02-01), Selsted et al.
patent: 6653442 (2003-11-01), Chang et al.
patent: 6713078 (2004-03-01), Lehrer et al.
patent: WO 96/16075 (1996-05-01), None
patent: WO 97/08199 (1997-06-01), None
patent: WO 99/11663 (1999-03-01), None
patent: WO 99/13080 (1999-03-01), None
patent: WO 00/12842 (2000-05-01), None
patent: WO 03/105883 (2003-12-01), None
Ahmad et al., “Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity,”Biochemica et Biophysica Acta1237:109-114 (1995).
Bals et al., “Mouse β-Defensin 1 Is a Salt-Sensitive Antimicrobial Peptide Present in Epithelia of the Lung and Urogenital Tract,”Infect. Immun.66(3):1225-1232 (1998).
Blond et al., “The cyclic strucutre of microcin J25, a 21-residue peptide antibiotic formEscherichia coli,”Eur. J. Biochem.259:747-755 (1999).
Derua et al., “Analysis of the Disulfide Linkage Pattern in Circulin A and B; HIV-Inhibitory Macrocyclic Peptides,”Biochem. Biophys. Res. Commun.228:632-638 (1996).
Gålvez et al., “Purification and Amino Acid composition of Peptide Antibiotic AS-48 Produced byStreptococcus(Enterococcus)faecalissubsp.liquefaciensS-48,”Antimicrob. Agents Chemother. 33(4):437-441 (1989).
Goldman et al., “Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cyctic Fibrosis,”Cell88:553-560 (1997).
Gustafson et al., “Circulins A and B: Novel HIV-Inhibitory Macrocyclic Peptides from the Tropical TreeChassalia parvifolia,” J. Amer. Chem. Soc.116:9337-9338 (1994).
Lehrer and Ganz, “Antimicrobial peptides in mammalian and insect host defence,”Current Opinion Immunol.11(1):23-27 (1999).
Lehrer et al., “Defensins: Endogenous Antibiotic Peptides of Animal Cells,”Cell64:229-230 (1991).
Munk et al., “The θ-defensin, retrocyclin, inhibits HIV-1 entry,”AIDS Res. Hum. Retroviruses19(10):875-881 (2003).
Smith et al., “Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid,”Cell85:229-236 (1996).
Tam et al., “Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-βstrand cystine knot framework,”Biochem. Biophys. Res. Commun.267(3):783-790 (2000).
Tang et al., “A cyclic antimicrobial peptide produced in primate leukocytes by the litigation of two truncated α-defensins,”Science286(5439):498-502 (1999).
Tang and Selsted, “Characterization of the Disulfide Motif in BNBD-12, and Antimicrobialβ-Defensin Peptide from Bovine Neutrophils,”J. Biol. Chem.268:6649-6653 (1993).
Tran, Dat Q., “Isolation, synthesis, and biological properties of cyclic defensins: structure-activity relationships and comparison with protegrin PG-1” Dissertation, University of California, Irvine, Thesis Defense May 1, 2001.
Valore et al., “Human β-Defensin-1: An Antimicrobial Peptide of Urogenital Tissues,”J. Clin. Invest.101:1633-1642 (1998).
Wade et al., “AII-D amino acid-containing channel-forming antibiotic peptides,”Proc. Natl. Acad. Sci. USA87:4761-4765 (1990).
Wu et al., “Proteintrans-splicing by a split intein encoded in a split DnaE gene ofSynechocystissp. PCC6803,”Proc. Natl. Acad. Sci. USA95:9226-9231 (1998).
Zanetti et al., “Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain,”FEBS Lett.347:1-5 (1995).
Selsted Michael E.
Tran Dat Q.
Harle Jennifer Ione
McDermott & Will & Emery
The Regents of the University of California
Tsang Cecilia J.
LandOfFree
Antimicrobial theta defensins, analogs thereof, and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial theta defensins, analogs thereof, and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial theta defensins, analogs thereof, and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3653236